Upkara
Ann Arbor
About Upkara
Upkara operates as a biotechnology company that specializes in developing biopreservation technologies. The company develops a biopreservation technology platform to eliminate the cold chain requirements of therapeutics, vaccines, and reagents. In addition, it provides an anhydrobiotic vitrification technology that eliminates the need for temperature control, and its rapid stabilization process preserves products in a proprietary medium, protecting them from temperature extremes. This technology also enables biologics, vaccines, nucleic acids, blood products, and others, to be stored at ambient and varying temperatures without impact on function.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.2M
- Funding stage: Early Stage Venture
- Last round: Series A (Apr 2023)
- Website: upkara.com
- Phone: (248) 567-9616
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/upkara-62580 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.